DR info

臨床試験数 : 19 / 薬物数 : 28 - (DrugBank : 10) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 65

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Bromocriptine
   First affiliated hospital of Sun Yat-sen University
      2012   -   ChiCTR-ONC-12002194   -
Cabergoline
   Federico II University
      2007   -   NCT00460616   Italy;
   Seoul National University Hospital
      2018   -   NCT03457389   Korea, Republic of;
   Universidade Federal do Rio de Janeiro
      2010   Phase 2/Phase 3   NCT01620138   Brazil;
Clomiphene citrate
   Federal University of São Paulo
      2004   Phase 2   NCT00697814   Brazil;
Curcumin
   Mashhad University of Medical Sciences
      2011   Phase 1   NCT01344291   Iran, Islamic Republic of;
Dexamethasone
   National Cancer Institute (NCI)
      2010   Phase 1   NCT01088763   Canada;United States;
Dopamine Agonists
   Leiden University Medical Center
      2019   Phase 4   NCT04107480   Netherlands;
Dopamine agonist treatment
   First Affiliated Hospital, Sun Yat-Sen University
      2016   -   NCT03353025   China;
Drug treatment
   Zhebao Wu
      2018   -   NCT03717454   -
Endoscopic trans-sphenoidal adenoma resection
   Leiden University Medical Center
      2019   Phase 4   NCT04107480   Netherlands;
Gamma-secretase/Notch signalling pathway inhibitor RO4929097
   National Cancer Institute (NCI)
      2010   Phase 1   NCT01088763   Canada;United States;
Genotropin Miniqu
   Amar Agha, Beaumont Hospital
      2009   -   EUCTR2009-010918-30-IE   Ireland;
Genotropin Miniquick
   Amar Agha, Beaumont Hospital
      2009   -   EUCTR2009-010918-30-IE   Ireland;
HCQ/CQ and CAB combined treatment
   Zhebao Wu
      2018   -   NCT03400865   China;
Lapatinib
   Cedars-Sinai Medical Center
      2009   Phase 2   NCT00939523   United States;
Pasireotide
   Novartis Pharma Services AG
      2009   Phase 2   EUCTR2008-007348-32-FR   France;Germany;Italy;Spain;
      2009   Phase 2   EUCTR2008-007348-32-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States;
   Universidade Federal do Rio de Janeiro
      2010   Phase 2/Phase 3   NCT01620138   Brazil;
   Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
      2008   -   EUCTR2006-007036-95-DE   Germany;
Ropinirole
   Columbia University
      2016   Phase 1/Phase 2   NCT03038308   United States;
SOM230
   NOVARTIS FARMA
      2009   -   EUCTR2008-007348-32-IT   France;Germany;Italy;Spain;
   Novartis Pharma Services AG
      2009   Phase 2   EUCTR2008-007348-32-FR   France;Germany;Italy;Spain;
      2009   Phase 2   EUCTR2008-007348-32-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States;
   Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
      2008   -   EUCTR2006-007036-95-DE   Germany;
Transsphenoidal surgery treatment
   First Affiliated Hospital, Sun Yat-Sen University
      2016   -   NCT03353025   China;